Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
Alejandro G Torres Chavez, Mary K McKenna, Anmol Gupta, et al.
Frontiers in Immunology
|
August 14, 2025
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
Alejandro G Torres Chavez, Mary K McKenna, Anmol Gupta, et al.
Cancer Immunology Research
|
September 19, 2022
Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors
Pradip Bajgain, Alejandro G Torres Chavez, Kishore Balasubramanian, et al.
Cancer Discovery
|
June 9, 2018
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
Sujita Sukumaran, Norihiro Watanabe, Pradip Bajgain, et al.
Journal for Immunotherapy of Cancer
|
May 12, 2018
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation
Pradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, et al.
Oncoimmunology
|
February 10, 2017
Fine-tuning the CAR spacer improves T-cell potency
Norihiro Watanabe, Pradip Bajgain, Sujita Sukumaran, et al.
Molecular Therapy. Oncology
|
April 10, 2024
A dual-luciferase bioluminescence system for the assessment of cellular therapies
Alejandro G Torres Chavez, Mary K McKenna, Kishore Balasubramanian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 28, 2017
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
Somala Mohammed, Sujita Sukumaran, Pradip Bajgain, et al.
Journal for Immunotherapy of Cancer
|
November 24, 2021
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
Saisha A Nalawade, Paul Shafer, Pradip Bajgain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 12, 2013
Kinetics of tumor destruction by chimeric antigen receptor-modified T cells
Usanarat Anurathapan, Robert C Chan, Hakeem F Hindi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
Alejandro G Torres Chavez, Mary K McKenna, Anmol Gupta, et al.
Frontiers in Immunology
|
August 14, 2025
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
Alejandro G Torres Chavez, Mary K McKenna, Anmol Gupta, et al.
Cancer Immunology Research
|
September 19, 2022
Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors
Pradip Bajgain, Alejandro G Torres Chavez, Kishore Balasubramanian, et al.
Cancer Discovery
|
June 9, 2018
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
Sujita Sukumaran, Norihiro Watanabe, Pradip Bajgain, et al.
Journal for Immunotherapy of Cancer
|
May 12, 2018
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation
Pradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, et al.
Oncoimmunology
|
February 10, 2017
Fine-tuning the CAR spacer improves T-cell potency
Norihiro Watanabe, Pradip Bajgain, Sujita Sukumaran, et al.
Molecular Therapy. Oncology
|
April 10, 2024
A dual-luciferase bioluminescence system for the assessment of cellular therapies
Alejandro G Torres Chavez, Mary K McKenna, Kishore Balasubramanian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 28, 2017
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
Somala Mohammed, Sujita Sukumaran, Pradip Bajgain, et al.
Journal for Immunotherapy of Cancer
|
November 24, 2021
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
Saisha A Nalawade, Paul Shafer, Pradip Bajgain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 12, 2013
Kinetics of tumor destruction by chimeric antigen receptor-modified T cells
Usanarat Anurathapan, Robert C Chan, Hakeem F Hindi, et al.
Page
of 2